ORAMED PHARMACEUTICALS INC. - 24 Apr 2025 SCHEDULE 13D Report for Alpha Tau Medical Ltd. Ordinary shares, no par value (DRTS)

Filing Manager
ORAMED PHARMACEUTICALS INC.
Reporting Manager
Oramed Pharmaceuticals Inc.
Security
Alpha Tau Medical Ltd. Ordinary shares, no par value
Symbol
DRTS
Shares outstanding
70,585,898 shares
Disclosed Ownership
14,110,121 shares
Ownership
20%
Form type
SCHEDULE 13D
Filing time
01 May 2025, 13:59:57 UTC
Date of event
24 Apr 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Oramed Pharmaceuticals Inc. 20% 14,110,121 0 14,110,121 /s/ Avraham Gabay Avraham Gabay, Chief Financial Officer 0001176309
Oramed Ltd. 20% 14,110,121 0 14,110,121 /s/ Avraham Gabay Avraham Gabay, Chief Financial Officer